Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study

BACKGROUND: Thyroglobulin (Tg) is a specific tumor marker for differentiated thyroid cancer (DTC). However, in the presence of an antithyroglobulin antibody (TgAb), it becomes unreliable. The purpose of the study was to assess the long-term outcome of DTC patients with raised TgAb. METHOD: In a retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ora, Manish, Nazar, Aftab Hasan, Mishra, Prabhakar, Barai, Sukanta, Arya, Amitabh, Pradhan, Prasanta Kumar, Gambhir, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048259/
https://www.ncbi.nlm.nih.gov/pubmed/33858456
http://dx.doi.org/10.1186/s13044-021-00099-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048259/
https://www.ncbi.nlm.nih.gov/pubmed/33858456
http://dx.doi.org/10.1186/s13044-021-00099-w

Ejemplares similares